Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
Emma A VermeulenCoby EelderinkTiny HoekstraAdriana J van BallegooijenPieter RaijmakersJoline W BeulensMartin H de BorstMarc G VervloetPublished in: Trials (2022)
Netherlands Trial Register, NL8252 (registered December 2019), EU clinical Trial Register 2019-001306-23 (registered November 2019).